DOE's US$4.2B conditional commitment could finance 433 MW of reactor uprates; Vistra must meet conditions before funding.

BWXT announced Oct. 5 that its BANR reactor technology was selected for a proposed Belledune plant of up to 50 MWe; a ...

Curaleaf filed a notice with Canadian regulators on Oct. 6 to vary its Aurora offer; the revised terms imply US$5 a share, up ...

Ohio's Oct. 5 adult-use cannabis limits cap edibles at 10 mg of THC per serving; Curaleaf last reported five stores in the ...

Blaize expects about US$0.5M of Q3 revenue, leaving most guided 2026 sales for Q4 as its NeoTensr receivable remains largely ...

Emera shareholders are expected to own about 60 per cent of the combined utility, which the companies estimate at C$72B in ...

The 20-year Google agreement supports 890 MW of new nuclear capacity; a separate 15-year deal covers 2,700 MW already ...

Viking starts an oral VK2735 maintenance trial in about 195 adults, testing tablets after 21 weeks of injections through week ...

Franco-Nevada paid C$22.2M for 10 million existing Kenorland shares from two holders, taking a 12.42% stake without a new ...

Vireo Growth Inc. announced an 8.5 per cent US$60M loan on Oct. 5, allocating about US$49M to New York debt and US$11M to ...

Rezolute says the FDA urged a pre-BLA meeting after its 63-patient Phase 3 sunRIZE trial missed both main endpoints in ...

Kenmare confirms a possible cash offer covering 89,228,161 issued shares; IRH must state its bid intention by Nov. 17.